SCHEMBL26074872

SCHEMBL26074872

CCOc1cccc(-c2ccc(-c3cc(CC)c4cc(F)ccc4n3)s2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 4/20 0.44
▸ TP53 P04637 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ WRN Q14191 1/20 0.39
▸ NR3C1 P04150 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ NOTUM Q6P988 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ TDP1 Q9NUW8 3/20 0.39
▸ HTT P42858 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ ESR1 P03372 2/20 0.38
▸ ESR2 Q92731 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ ESRRB O95718 1/20 0.38
▸ ESRRA P11474 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23590127 0.87 DHODH (0.55) DHODHTP53SMN1; SMN2MEN1KMT2A
SCHEMBL26075545 0.86 DHODH (0.48) DHODHTP53SMN1; SMN2MEN1KMT2A
SCHEMBL26075529 0.78 ESR1 (0.53) DHODHTP53SMN1; SMN2MEN1KMT2A
SCHEMBL29973103 0.77 DHODH (0.58) DHODHTP53SMN1; SMN2MEN1KMT2A
SCHEMBL23578864 0.77 DHODH (0.58) DHODHTP53SMN1; SMN2MEN1KMT2A
SCHEMBL26074746 0.75 ESR1 (0.50) DHODHTP53SMN1; SMN2MEN1KMT2A
SCHEMBL26075172 0.75 MEN1 (0.44) DHODHTP53SMN1; SMN2MEN1KMT2A
SCHEMBL26074858 0.75 PLA2G2A (0.64) DHODHTP53SMN1; SMN2MEN1KMT2A
SCHEMBL23578798 0.75 RXFP1 (0.53) DHODHTP53SMN1; SMN2MEN1KMT2A
SCHEMBL29972871 0.75 RXFP1 (0.53) DHODHTP53SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD DHODH 1/4885TP53 522/4885SMN1; SMN2 3677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback